Plain-English translation of NCT06742385 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Crohn Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The SECURITY trial is testing a smartphone application called MedicWise that monitors your inflammatory bowel disease in real time and sends alerts to your care team if your disease activity changes. Both groups in this study will use the app to share health data, but only one group will have those alerts turned on so doctors can respond quickly. The trial wants to see whether this tight remote monitoring helps people spend more time in remission (when symptoms are controlled) compared to standard office visits alone.
Even though remote monitoring makes sense in theory—helping catch flare-ups early and adjust treatment—earlier studies haven't clearly proven it improves outcomes for people with inflammatory bowel disease. This trial is designed to test a more advanced app that collects data automatically (without you having to type everything yourself), which may work better than previous tools.
You likely qualify if…
You likely don't qualify if…
You will use the MedicWise app on your smartphone to regularly share health information like your symptoms and any lab results your doctor orders—much of this data is collected automatically, so you won't have to enter everything manually. Depending on which group you're assigned to, your doctor's team may receive real-time alerts if your disease activity changes, allowing them to adjust your treatment sooner. You'll continue this monitoring for 12 months while staying on your regular medications and attending standard clinic visits.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
France